PLSH — Panacea Life Sciences Holdings Balance Sheet
0.000.00%
- $2.91m
- $14.95m
- $2.38m
- 29
- 45
- 19
- 21
Annual balance sheet for Panacea Life Sciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.018 | 0.025 | 3.81 | 1.11 | 0.116 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.202 | 0 | 0.745 | 0.706 | 0.264 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 2.43 | 0.051 | 9.1 | 6.38 | 4.66 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.65 | 0.02 | 12.4 | 10.9 | 10.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 9.8 | 0.071 | 23.8 | 19.5 | 18 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.19 | 4.9 | 10.1 | 15.1 | 19.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.58 | 3.09 | 16.7 | 21.6 | 26.3 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 4.22 | -3.02 | 7.1 | -2.14 | -8.29 |
Total Liabilities & Shareholders' Equity | 9.8 | 0.071 | 23.8 | 19.5 | 18 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |